Skip to search formSkip to main contentSkip to account menu

altretamine/cisplatin/cyclophosphamide protocol

Known as: CDDP/CTX/HMM, Altretamine/Cisplatin/Cyclophosphamide, HCC 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BackgroundHepatocellular carcinoma (HCC) is a typical malignancy in a background of chronic inflammation. Th17 cells (a major… 
Review
2009
Review
2009
Objective:An important area concerning morbidity among infants with congenital heart defects (CHD) is related to feeding problems… 
Highly Cited
2004
Highly Cited
2004
OBJECTIVES More than 85% of children born today with chronic medical conditions will live to adulthood, and many should transfer… 
Highly Cited
2001
Highly Cited
2001
Recently, the implementation of screening programs using α‐fetoprotein (AFP) and ultrasonography in high risk populations has… 
Highly Cited
2000
Highly Cited
2000
BACKGROUND beta(2)-Microglobulin (beta(2)m) is a major component of dialysis-related amyloidosis. The available therapeutic… 
Highly Cited
1997
Highly Cited
1997
BACKGROUND The oldest-old population (> or = 84 years of age) is growing rapidly and consumes a disproportionate amount of health… 
Highly Cited
1995
Highly Cited
1995
BACKGROUND There has been a continuing debate about the overall benefit of cholesterol lowering. We performed a novel meta…